Vanderbilt and Stanford Professors Discuss 2021 Drug Pricing Reform in JAMA Article, Note Power of Value Assessments and Medicare Negotiation During COVID-19 Pandemic

Dr. Stacie Dusetzina of Vanderbilt University School of Medicine and Dr. Michelle Mello of Stanford Law School and Stanford School of Medicine recently published an article in JAMA Health Forum on drug pricing reform. The authors propose several solutions to high drug prices in the United States, including Medicare drug price negotiation, utilizing value-based pricing, and doing away with percentage-based reimbursement.

The authors remark, “In short, the COVID-19 vaccines and aducanumab make the consequences of the nation’s choices about drug price regulation starkly clear. The key takeaway, as Congress turns its attention back to addressing prescription drug costs, is that centralized price negotiation must come to Medicare.” Read the article here.

(Source: Stacie Dusetzina & Michelle Mello, JAMA Health Forum, 7/9/21)